Literature DB >> 336198

Intermittent high single-dose ftorafur: phase I clinical trial with a pharmacologic-toxicity correlation.

S W Hall, M Valdivieso, R S Benjamin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336198

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  4 in total

1.  Ftorafur: a self-limiting source of 5-fluorouracil?

Authors:  L M van Putten; P Lelieveld; C Pantarotto; M Salmona; F Spreafico
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Changes in toxic and antitumor properties of ftorafur by induction or inhibition of the microsomal enzymes activity.

Authors:  G A Belitsky; V M Bukhman; I A Konopleva
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.

Authors:  B Schultze; W Jellinghaus; G Weis; V Müller; W Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Effects of 5-Fluorouracil prodrugs on the central nervous system in mice and rats.

Authors:  K Toide; N Unemi; T Segawa
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.